---
title: "Passage Bio (PASG.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/PASG.US/norm.md"
symbol: "PASG.US"
name: "Passage Bio"
parent: "https://longbridge.com/en/quote/PASG.US.md"
datetime: "2026-05-21T22:31:17.808Z"
locales:
  - [en](https://longbridge.com/en/quote/PASG.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/PASG.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/PASG.US/norm.md)
---

# Passage Bio (PASG.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -2.36 | -4.08 | -2.44 | -2.96 | -4.96 |
| ROE | -198.22% | -208.25% | -89.35% | -88.37% | -114.15% |
| Revenue | - | - | - | - | - |
| Net income | -7.56M | -12.98M | -7.75M | -9.38M | -15.40M |
| Operating income | -8.25M | -10.34M | -8.65M | -10.33M | -13.82M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 36.46M | 62.28M | 74.16M | 79.20M | 86.01M |
| Leverage | 3.10 | 3.32 | 2.38 | 2.07 | 1.84 |
| BVPS | 3.66 | 5.89 | 9.79 | 12.04 | 15.03 |
| Turnover | - | - | - | - | - |
| Cash & STI | 33.34M | 46.30M | 52.77M | 57.63M | 63.36M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 1.48M | 14.28M | 18.16M | 18.61M | 19.06M |
| Net debt | -27.58M | -22.29M | -28.44M | -32.90M | -38.24M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -12.99M | -6.48M | -4.85M | -6.33M | -13.85M |
| Investing CF | 20000.00 | 0.0000 | 0.0000 | 585000.00 | 39.63M |
| Financing CF | - | 9000.00 | 0.0000 | 14000.00 | - |
| Free CF | -5.53M | -3.37M | -2.39M | -2.72M | -10.32M |
| OCF coverage | - | - | - | - | - |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | - | - |